All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Thymoma Type A | NCIT_C6454 | [A thymic epithelial neoplasm characterized by the presence of spindle and/or oval neoplastic epithelial cells. Lymphocytic infiltration is minimal or absent. It may be associated with myasthenia gravis or pure red cell aplasia. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. Approximately 20% of the cases occur as stage II or stage III tumors. Type A thymoma generally behaves as a benign tumor and the overall survival is reported to be 100% at 5 and 10 years.] |
| Danish White Mice MRS Street, 1932 | NCIT_C15026 | |
| Increased Time To Concomitant Drug Peak Blood Concentration | NCIT_C54612 | [Increased time following concomitant drug administration at which the peak drug blood concentration occurs.] |
| C-SSRS Already Enrolled Subjects - Suicidal Behavior (Since Study Start) | NCIT_C107077 | [Columbia-Suicidality Severity Rating Scale Already Enrolled Subjects (C-SSRS Already Enrolled Subjects ) Suicidal behavior was present during the assessment period? (Since Study Start).] |
| 3p14 Loss of Heterozygosity | NCIT_C146641 | [A molecular abnormality that results in monoallelic loss of function mutations located within 3p14.] |
| ST Simonex, Heston, Jax Substrains Mouse | NCIT_C15027 | |
| Increased Concomitant Drug AUC | NCIT_C54613 | [Increased area under the plot of plasma concentration of a concomitant drug against time after its administration.] |
| C-SSRS Already Enrolled Subjects - Completed Suicide (Prior to Study Entry) | NCIT_C107078 | [Columbia-Suicidality Severity Rating Scale Already Enrolled Subjects (C-SSRS Already Enrolled Subjects ) Completed suicide? (Prior to Study Entry)] |
| Immune System Disorders, CTCAE | NCIT_C143186 | |
| K Mouse | NCIT_C15028 | |
| Decreased Concomitant Drug AUC | NCIT_C54614 | [Decreased area under the plot of plasma concentration of a concomitant drug against time after its administration.] |
| C-SSRS Already Enrolled Subjects - Completed Suicide (Since Study Start) | NCIT_C107079 | [Columbia-Suicidality Severity Rating Scale Already Enrolled Subjects (C-SSRS Already Enrolled Subjects ) Completed suicide? (Since Study Start)] |
| Flushing, CTCAE 5.0 | NCIT_C146643 | [A disorder characterized by episodic reddening of the skin, especially face, neck, or chest.] |
| LC Strong (2) | NCIT_C15029 | |
| Decreased Concomitant Drug Peak Blood Concentration | NCIT_C54615 | [Decreased maximum (peak) concentration of a concomitant drug observed after its administration.] |
| Skin Atrophy, CTCAE 5.0 | NCIT_C146644 | [A disorder characterized by the degeneration and thinning of the epidermis and dermis.] |
| FANCM Gene Mutation | NCIT_C132004 | [A change in the nucleotide sequence of the FANCM gene.] |
| Fanconi Anemia Complementation Group Gene Mutation | NCIT_C159204 | [A change in the nucleotide sequence for a gene that is a member of the Fanconi anemia complementation group.] |
| FANCM Gene | NCIT_C54228 | [This gene plays a role in transcriptional regulation and ubiquitination.] |
| RAD51B Gene Mutation | NCIT_C132005 | [A change in the nucleotide sequence of the RAD51B gene.] |